Ehud Razin

Prof. Ehud Razin


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Molecular Cell
Verified
Journal Article
Closed access
YOYifat Ofir-Birin
Yifat Ofir-Birin
PFPengfei Fang
Pengfei Fang
SBSteven P. Bennett
Steven P. Bennett
HZHui-Min Zhang
Hui-Min Zhang
JWJing Wang
Jing Wang
MGMin Guo
Min Guo

1 August 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TETal Hadad Erlich
Tal Hadad Erlich
ZYZohar Yagil
Zohar Yagil
GKGillian Kay
Gillian Kay
APAlona Peretz
Alona Peretz
HMHelena Migalovich-Sheikhet
Helena Migalovich-Sheikhet
EREhud Razin
Ehud Razin

1 November 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EREhud Razin
Ehud Razin
ZZZhao Cheng Zhang
Zhao Cheng Zhang
HNHovav Nechushtan
Hovav Nechushtan
SFShahar Frenkel
Shahar Frenkel
YLYu-Nee Lee
Yu-Nee Lee
JRJuan Rivera
Juan Rivera
Microphthalmia (mi) is a transcription factor that plays a major role in the regulation of growth and function in mast cells and melanocytes. Association ofmi with other proteins is a critical step in the regulation of mi-mediated transcriptional activation. We found protein kinase C-interacting protein 1 (PKCI) specifically associated withmi in yeast two-hybrid screening. Immunoprecipitation ofmi from quiescent rat basophilic leukemic cells or mouse melanocytes resulted in the specific co-immunoprecipitation of PKCI. This association was significantly reduced on engagement of the surface FcεRI of mast cells or engagement of the Kit receptor on melanocytes. Hence, cell activation caused disengagement of mi from PKCI. Microphthalmia was previously shown to activate the mouse mast cell protease 6 (mMCP-6) promoter. Cotransfection of miwith PKCI in NIH 3T3 fibroblasts containing an mMCP-6 promoter-luciferase reporter demonstrated an up to 94% inhibition ofmi-mediated transcriptional activation. PKCI by itself, although localized in the cytosol and nucleus of the cells, has no known physiological function and did not demonstrate transcriptional activity. Its ability to suppres mi transcriptional activity in the transient transfected fibroblast system suggests that it can function in vivo as a negative regulator ofmi-induced transcriptional activation.

1 March 2000 in Blood
Verified
Journal Article
Open access
HNHovav Nechushtan
Hovav Nechushtan
MLMichael Leitges
Michael Leitges
CCCellina Cohen
Cellina Cohen
GKGillian Kay
Gillian Kay
EREhud Razin
Ehud Razin
The antigen-mediated activation of mast cells by means of IgE antibodies bound to the cell surface leads to direct interactions between FcɛRI receptor cytoplasmic domains and various intracellular proteins. These interactions initiate diverse signal-transduction pathways, and the activation of these pathways results in the immediate release of proinflammatory agents. A delayed response also occurs and includes the release of various cytokines. It is clear that the activation of kinases is a requirement for the exocytosis observed in mast cells. In addition to the tyrosine phosphorylation of the affected system by soluble tyrosine kinases, activity of protein kinase C (PKC) results in serine or threonine phosphorylation of multiple protein substrates. In this study, we found that mast cells derived from PKCβ-deficient mice produce less interleukin 6 in response to IgE-Ag. The inhibition of exocytosis in the PKCβ-deficient mast cells occurred whether the stimuli were due to the aggregation of the mast cell surface FcɛRI or to the calcium ionophore, ionomycin. However, no significant changes were observed in the proliferative response of the mast cells to interleukin 3 (IL-3) or in their apoptotic rate after IL-3 depletion.

1 October 2005 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
YLYu-Nee Lee
Yu-Nee Lee
EREhud Razin
Ehud Razin
Reports of the biological multifunctional activity of various aminoacyl tRNA synthetases have recently accumulated in the literature. The primary function of these critical enzymes is to charge various tRNAs with their appropriate amino acids, thus producing the building blocks of protein synthesis. We have previously shown that lysyl tRNA synthetase (LysRS) associates with microphthalmia transcription factor (MITF) and regulates its activity by synthesis of Ap4A in mast cells. Here, we show for the first time that LysRS associates with another transcription factor, USF2, which unlike MITF, is ubiquitously expressed in eukaryotic cells. Using mast cells, we have found that USF2 is negatively regulated by Hint and Ap4A acts as a positive regulator of USF2 by a molecular mechanism similar to that described for MITF. Since USF2 plays a significant role in a variety of cellular functions, our finding suggests that LysRS and Ap4A may be involved in general regulation of gene transcription.

1 December 2004 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
ASAmir Sonnenblick
Amir Sonnenblick
CLCarmit Levy
Carmit Levy
EREhud Razin
Ehud Razin
Microphthalmia transcription factor (MITF) and STAT3 are two transcription factors that play a major role in the regulation of growth and function in mast cells and melanocytes. In the present study, we explored the MITF-PIAS3-STAT3 network of interactions, how these interactions regulate gene expression, and how cytokine-mediated phosphorylation of MITF and STAT3 is involved in the in vivo interplay between these three proteins. In NIH 3T3 cells stimulated via gp130 receptor, transfected MITF was found to be phosphorylated at S409. Such phosphorylation of MITF leads to PIAS3 dissociation from MITF and its association with STAT3. Activation of mouse melanoma and mast cells through gp130 or c-Kit receptors induced the mobilization of PIAS3 from MITF to STAT3. In mast cells derived from MITFdi/di mice, whose MITF lacks the Zip domain (PIAS3-binding domain), we found downregulation in mRNA levels of genes regulated by either MITF or STAT3. This regulatory mechanism is of considerable importance since it is likely to advance the deciphering of a role for MITF and STAT3 in mast cells and melanocytes.